Abstract: The present invention provides a composition comprising synergistic amounts of a compound of the formula (I) wherein X, E, R, A and Z are as defined herein, and at least one fungicidal active compound as defined herein. The compositions of the present invention find use as pesticides.
Type:
Grant
Filed:
June 3, 2002
Date of Patent:
March 7, 2006
Assignee:
Bayer Aktiengesellschaft
Inventors:
Stefan Dutzmann, Christoph Erdelen, Wolfram Andersch, Heinz-Wilhelm Dehne, Jürgen Hartwig, Klaus Stenzel, Wolfgang Krämer
Abstract: The present invention relates to compositions comprising sporocysts of at least one parasitic single-cell organism and at least one anticoagulant, and to their use for controlling harmful rodents.
Type:
Grant
Filed:
January 5, 2001
Date of Patent:
March 7, 2006
Assignee:
Bayer Aktiengesellschaft
Inventors:
Gerhard Hesse, Thomas Böcker, Stefan Endepols, Thomas Jäkel, Sermasakdi Hongnark
Abstract: The present invention relates to processes for preparing ethylene oxide (EO)-capped polyols in which removal of catalyst residues or salts formed by the neutralization of the basic catalyst is not required prior to discharging the polyol from the reactor because neutralization occurs during or after the starter charge of a subsequent batch. The inventive processes allow for the preparation of DMC-catalyzed intermediates and their base-catalyzed EO caps within the same reactor. Polyols produced by the processes of the invention have a high content of primary hydroxyl groups and may be useful for producing polyurethane foams, elastomers, sealants, coatings, adhesives and the like.
Abstract: A polymer composition useful to produce a vulcanizate having improved hot air aging properties is described. The polymer composition includes two components. The first component is a polymer having a main polymer chain derived from: (i) at least about 30% by weight of a first monomer which introduces at least one of a secondary carbon and a tertiary carbon to the backbone, and (ii) from 0 to about 70% by weight of at least one other monomer. The second component is a salt of a strong base and a weak acid, the salt comprising a metal selected from Group I of the Periodic Table of Elements. The polymer compositions may further comprise optional ingredients such as one or more of: a vulcanization system, a polycarbodiimide and a filler.
Abstract: A thermoplastic molding composition comprising poly(ester)carbonate is disclosed. The composition that is characterized by its flame resistance contains a PTFE blend in an amount of 0.2 to 0.6% and an organic salt of an alkali metal or alkaline earth metal in an amount of 0.01 to 0.1%. The PTFE blend contains a blending partner and PTFE wherein amount of PTFE is 30 to 70% relative to the weight of the PTFE blend.
Abstract: The invention relates to aqueous two-component polyurethane systems comprising vinyl polymer polyol dispersions modified with reactive diluents, to a process for preparing them and to use as coating materials.
Type:
Grant
Filed:
March 21, 2003
Date of Patent:
February 28, 2006
Assignee:
Bayer Aktiengesellschaft
Inventors:
Joachim Probst, Martin Melchiors, Gerhard Ruttmann, Thomas Stingl, Hartmut Ottensmann
Abstract: The invention relates to novel 7-amino-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.
Type:
Application
Filed:
April 22, 2003
Publication date:
February 23, 2006
Applicant:
Bayer HealthCare AG
Inventors:
Cristina Alonso-Alija, Heike Gielen-Haertwig, Martin Michels, Dagmar Karthaus, Hilmar Bischoff, Nils Burkhardt, Volker Geiss, Karl-Heinz Schlemmer, Nigel Cuthbert, Mary Fitzgerald, Graham Sturton, Ulrich Niewohner, Maria Niewohner
Abstract: Reagents that regulate human asparagine-hydroxylase and reagents which bind to human asparagine-hydroxylase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cardio-vascular disorders, anaemia, cancer, inflammatory diseases, fibrotic disorders, and CNS disorders.
Abstract: The invention relates to novel 5-ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.
Type:
Application
Filed:
May 5, 2003
Publication date:
February 23, 2006
Applicant:
Bayer Healthcare AG
Inventors:
Cristina Alonso-Alija, Heike Gielen-Haertwig, Martin Michels, Dagmar Karthaus, Hilmar Bischoff, Nils Burkhardt, Volker Geiss, Karl-Heinz Schlemmer, Nigel Cuthbert, Mary Fitzgerald, Graham Sturton, Ulrich Niewohner, Maria Niewohner
Abstract: This invention relates to a compound of Formula (I) wherein Y is CH or N; Ar1 is phenyl or pyridyl each optionally substituted with 1 or 2 substituents each selected independently from (C1-C3)alkoxy halo, OH, CF3, CN, NO2 and (C1-C3)alkyl, said alkyl being optionally substituted with CF3; Ar2 is phenyl or pyridyl each option-ally substituted with 1 or 2 substituents each independently selected from halo, OH, CN, NO2, CF3, (C1-C6)alkoxy, NR1R1, S(O)2R2, C(O)R3, and (C1-C6)alkyl optionally substituted with R4, and its use in treating hyper-proliferative disorders.
Type:
Application
Filed:
July 11, 2003
Publication date:
February 23, 2006
Applicant:
Bayer Pharmaceuticals Corporation
Inventors:
Chengzhi Zhang, Gaetan Ladouceur, Michael Burke
Abstract: The present invention provides polyamines which contain urea groups, a process for the preparation thereof and their use to produce adhesives, sealants, embedding compounds, moulded items or coatings.
Type:
Grant
Filed:
July 17, 2000
Date of Patent:
February 21, 2006
Assignee:
Bayer Aktiengesellschaft
Inventors:
Jörg Tillack, Lutz Schmalstieg, Wolfgang Puetz, Gerhard Ruttmann
Abstract: A mineral-filled, impact-resistant thermoplastic molding composition is disclosed. The composition contains at least one resin selected from the group consisting of polycarbonate and polyester carbonate B) impact resistance modifier, and C) wollastonite having carbon content greater than 0.1% relative to the weight of the wollastonite as determined by elemental analysis. Exhibiting high modulus of elasticity and a good toughness, in particular also at low temperatures, the composition is suitable for car body external applications.
Type:
Grant
Filed:
October 22, 2002
Date of Patent:
February 21, 2006
Assignee:
Bayer Aktiengesellschaft
Inventors:
Marc Vathauer, Andreas Seidel, Detlev Joachimi, Dieter Wittmann
Abstract: The display device with touch sensor according to the invention consists of an electrochromic cell known per se or a liquid crystal cell, which is located between two transparent plates, a transparent cover plate and a transparent support plate. A radiation source whose light enters the cover plate and illuminates it is arranged on at least one of the end faces of the transparent cover plate. At least one photodetector, in whose photosensitive solid angle range some or all of the cover plate surface lies, is mounted on the support plate is.
Abstract: The invention relates to insecticidal mixtures of spinosyns and agonists or antagonists of nicotinic acetylcholine receptors for protecting plants against attack by pests.
Abstract: The present invention relates to a process for suppressing the foaming of an aqueous system which involves combining water and at least one defoamer composition which has a hydroxyl equivalent molecular weight of at least 4000 Da and a cloud point less than or equal to 30° C. in 1% aqueous solution. The high hydroxyl equivalent molecular weight defoamers of the present invention exhibit excellent defoaming properties at a low cloud point. Additionally, defoamers of the present invention exhibit defoaming properties which are better than those of defoamers having the same cloud point which are based on polyoxyalkylene copolymers prepared in the presence of potassium hydroxide. The superior defoaming properties of the defoamers of the present invention are particularly useful in the manufacture or processing of food items.
Abstract: Disclosed is an assay for determining the presence and concentration of trypsin inhibitor in urine samples. The assay reagents, which may be used either in the liquid or dry states, include trypsin, a trypsin substrate and a polycarboxylic chelating agent. The inclusion of the chelating agent in the assay has been found to reduce variation in the assay results.
Type:
Grant
Filed:
April 30, 2001
Date of Patent:
February 21, 2006
Assignee:
Bayer Corporation
Inventors:
Gary E. Rehm, Michael J. Pugia, Paul F. Corey
Abstract: The present invention relates to a polyether urethane containing one reactive silane group and one or more polyether segments having a number average molecular weight of 1000 to 15,000, wherein the reactive silane groups are incorporated by the reaction of an isocyanate group with a compound corresponding to the formula wherein X represents identical or different organic groups which are inert to isocyanate groups below 100° C., provided that at least two of these groups are alkoxy or acyloxy groups, Y represents a linear or branched alkylene group containing 1 to 8 carbon atoms and R1 represents an organic group which is inert to isocyanate groups at a temperature of 100° C. or less.
Type:
Grant
Filed:
October 22, 2003
Date of Patent:
February 14, 2006
Assignee:
Bayer MaterialScience LLC
Inventors:
Richard R. Roesler, Derek L. Crawford, Kurt C. Frisch, Dinesh Pethiyagoda, Karsten Danielmeier
Abstract: The present invention relates to a process for the preparation of sulphonamide-substituted imidazotriazinones of the general formula (I) characterized in that compounds of the formula (II) are reacted with sulphuric acid and the products obtained are then reacted with thionyl chloride and converted in situ in an inert solvent using an amine into the compounds according to the invention and, if appropriate, reacted to give the corresponding salts, hydrates or N-oxides.
Type:
Grant
Filed:
May 5, 2005
Date of Patent:
February 14, 2006
Assignee:
Bayer HealthCare Aktiengesellschaft
Inventors:
Marc Nowakowski, Reinhold Gehring, Werner Heilmann, Karl-Heinz Wahl
Abstract: The invention relates to novel substituted imidazotriazinones, to a method for their production and to the use thereof for producing medicaments, in particular to improve perception, powers of concentration, learning capacity and/or memory retentiveness.
Type:
Grant
Filed:
February 11, 2002
Date of Patent:
February 14, 2006
Assignee:
Bayer Aktiengesellschaft
Inventors:
Maria Theresia Niewöhner, legal representative, Dagmar Schauss, Gerhard König, Martin Hendrix, Frank-Gerhard Böss, Franz-Josef van der Staay, Rudy Schreiber, Karl-Heinz Schlemmer, Toshiya Moriwaki, Ulrich Niewöhner, deceased
Abstract: The present invention relates to a semi-hydrochloride of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid, to processes for its preparation and to antibacterial compositions comprising it. The semihydrochloride of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.